In another report, the (L+B) treatment in RCTs for T2D improved fasting blood glucose [32,33], increased insulin sensitivity [33], modestly decreased HbA1c [11,32], and reduced inflammation and oxidative stress [32]. The gene discussed is INS; the disease is type 2 diabetes mellitus.